文献速递生殖医学

低血清抗苗勒管激素与接受随机对照试验筛选的不育男性精液质量差相关

Low-serum antimüllerian hormone is linked with poor semen quality in infertile men screened for participation in a randomized controlled trial.
PubMed 文献 · Fertil Steril · 2024-03-24

本研究在不育男性接受First in Treating Male Infertility Study随机对照试验筛选时,纳入400名参与者,分析血清抗苗勒管激素(AMH)浓度与精液质量的关系。结果显示,AMH浓度最低四分位组男性的精子浓度、总数、活力和前向运动比例均低于其他四分位组;精子浓度<2百万/mL及活力<20%者AMH浓度更低。结论提示低血清AMH与精液质量差相关,可能在男性不育评估中具有临床价值。

要点

  • AMH最低四分位组精子浓度、总数、活力和前向运动均低于其他组。
  • 精子浓度<2百万/mL者AMH低于2-16百万/mL和>16百万/mL者。
  • 精子活力<20%者AMH低于20%-42%和>42%者。

核心结论

  • 低血清AMH浓度与不育男性精液质量差相关,提示血清AMH在男性不育评估中可能有临床价值。

研究设计与样本

  • 不育男性在参加First in Treating Male Infertility Study筛选时纳入,该试验为双盲、安慰剂对照、1:1、单中心随机对照试验;筛选访视时400名参与者提供精液样本并检测血清AMH浓度。

主要发现

  • 按血清AMH浓度四分位分组(Q1-Q4),最低四分位组精子浓度(1×10^6/mL)为Q1 8.0 vs Q2 10.4 vs Q3 11.0 vs Q4 13.0。
  • 最低四分位组总精子数(1×10^6)为Q1 29.1 vs Q2 38.2 vs Q3 44.4 vs Q4 55.7。
  • 最低四分位组精子活力(%)为Q1 41 vs Q2 57 vs Q3 50 vs Q4 53。
  • 最低四分位组前向运动精子比例(%)为Q1 31 vs Q2 44 vs Q3 35 vs Q4 40。
  • 精子浓度<2百万/mL者血清AMH为31 pmol/L,低于2-16×10^6/mL者的38 pmol/L和>16×10^6/mL者的43 pmol/L。

临床怎么用

  • 原文结论认为低血清AMH浓度与不育男性精液质量差相关,血清AMH浓度在男性不育评估中可能有临床价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate possible associations between serum antimüllerian hormone (AMH) concentration and semen quality in infertile men. Studies investigating the associations between serum AMH concentration and semen quality in infertile men have shown conflicting results. DESIGN: Infertile men were included during screening for participation in the First in Treating Male Infertility Study, a double-blinded, placebo-controlled, 1:1, single-center randomized controlled trial. SETTING: Not applicable. PATIENTS: At the screening visit, 400 participants produced a semen sample and had their serum analyzed for AMH concentration. INTERVENTION: Not applicable. MAIN OUTCOME MEASURES: Serum AMH concentration and semen quality. RESULTS: All men were stratified according to serum AMH concentrations in quartiles (Q1-Q4). Men in the lowest quartile had a lower sperm concentration (1 × 106/mL) (Q1: 8.0 vs. Q2: 10.4 vs. Q3: 11.0 vs. Q4: 13.0), total sperm count (1 × 106) (Q1: 29.1 vs. Q2: 38.2 vs. Q3: 44.4 vs. Q4: 55.7), sperm motility (%) (Q1: 41 vs. Q2: 57 vs. Q3: 50 vs. Q4: 53), and progressive sperm motility (%) (Q1: 31 vs. Q2: 44 vs. Q3: 35 vs. Q4: 40) compared with the other quartiles. Moreover, men with a sperm concentration <2 million/mL had a lower serum AMH concentration compared with men having 2-16 × 106 /mL and >16 × 106/mL (31 pmol/L vs. 38 pmol/L vs. 43 pmol/L, respectively). In accordance, men with sperm motility <20% had a lower serum AMH concentration compared with men with sperm motility 20%-42%, and >42% (31 pmol/L vs. 43 pmol/L. vs. 39 pmol/L, respectively). CONCLUSION: This study shows that low serum AMH concentration is associated with poor semen quality in infertile men, which implies that serum AMH concentration may have clinical value during the evaluation of male infertility. CLINICAL TRIAL REGISTRATION NUMBER: NCT05212337.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Holt R, Yahyavi SK, Wall-Gremstrup G, et al. Low-serum antimüllerian hormone is linked with poor semen quality in infertile men screened for participation in a randomized controlled trial. Fertil Steril. 2024. PMID: 38522503. doi:10.1016/j.fertnstert.2024.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。